Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in thousands)
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 92 | 172 | 139 | 189 | 109 |
| Accounts receivable | -12 | 226 | -37 | -10 | -141 |
| Accounts payable and accrued liabilities | N/A | N/A | -78 | -89 | N/A |
| Other Working Capital | 57 | 259 | -157 | -46 | -163 |
| Other Operating Activity | -174 | -715 | -395 | -823 | -565 |
| Operating Cash Flow | $-38 | $-57 | $-527 | $-779 | $-760 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -3 | -12 | 0 | -13 | -21 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 239 |
| Investing Cash Flow | $-3 | $-12 | $0 | $-13 | $219 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 2 | -20 | -19 | -18 | -17 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,727 |
| Financing Cash Flow | $2 | $-20 | $-19 | $-18 | $1,710 |
| Beginning Cash Position | 55 | 145 | 691 | 1,501 | 332 |
| End Cash Position | 17 | 55 | 145 | 691 | 1,501 |
| Net Cash Flow | $-39 | $-90 | $-546 | $-810 | $1,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38 | -57 | -527 | -779 | -760 |
| Capital Expenditure | -3 | N/A | N/A | -13 | -21 |
| Free Cash Flow | -40 | -57 | -527 | -792 | -780 |